Global Prostate Cancer Treatment Drugs Market Growth 2018-2023

October 2018 | 135 pages | ID: GAD1F9929B4EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Prostate cancer is the most common cancer among men, the key risk factors for prostate cancer development is being old age, genetic, obesity and race.
Over the next five years, LPI(LP Information) projects that Prostate Cancer Treatment Drugs will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Prostate Cancer Treatment Drugs market for 2018-2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Prostate Cancer Treatment Drugs market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Enzalutamid
• Abiraterone
• Leuprolide
• Goserelin
• Triptorelin
• Histrelin
• Degarelix
• Sipuleucel-T
• Docetaxel

Segmentation by application:

• Hospital
• Research Institution
• Clinic
• Drugstore

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Tolmar
• Astellas Pharma
• AstraZeneca
• Ferring Pharmaceuticals
• Johnson & Johnson
• Abbott
• Sanofi
• Ipsen
• Novartis
• Bayer

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Prostate Cancer Treatment Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Prostate Cancer Treatment Drugs market by identifying its various subsegments.
• Focuses on the key global Prostate Cancer Treatment Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Prostate Cancer Treatment Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Prostate Cancer Treatment Drugs submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Prostate Cancer Treatment Drugs Consumption 2013-2023
  2.1.2 Prostate Cancer Treatment Drugs Consumption CAGR by Region
2.2 Prostate Cancer Treatment Drugs Segment by Type
  2.2.1 Enzalutamid
  2.2.2 Abiraterone
  2.2.3 Leuprolide
  2.2.4 Goserelin
  2.2.5 Triptorelin
  2.2.6 Histrelin
  2.2.7 Degarelix
  2.2.8 Sipuleucel-T
  2.2.9 Docetaxel
  2.2.10 Cabazitaxel
2.3 Prostate Cancer Treatment Drugs Consumption by Type
  2.3.1 Global Prostate Cancer Treatment Drugs Consumption Market Share by Type (2013-2018)
  2.3.2 Global Prostate Cancer Treatment Drugs Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Prostate Cancer Treatment Drugs Sale Price by Type (2013-2018)
2.4 Prostate Cancer Treatment Drugs Segment by Application
  2.4.1 Hospital
  2.4.2 Research Institution
  2.4.3 Clinic
  2.4.4 Drugstore
2.5 Prostate Cancer Treatment Drugs Consumption by Application
  2.5.1 Global Prostate Cancer Treatment Drugs Consumption Market Share by Application (2013-2018)
  2.5.2 Global Prostate Cancer Treatment Drugs Value and Market Share by Application (2013-2018)
  2.5.3 Global Prostate Cancer Treatment Drugs Sale Price by Application (2013-2018)

3 GLOBAL PROSTATE CANCER TREATMENT DRUGS BY PLAYERS

3.1 Global Prostate Cancer Treatment Drugs Sales Market Share by Players
  3.1.1 Global Prostate Cancer Treatment Drugs Sales by Players (2016-2018)
  3.1.2 Global Prostate Cancer Treatment Drugs Sales Market Share by Players (2016-2018)
3.2 Global Prostate Cancer Treatment Drugs Revenue Market Share by Players
  3.2.1 Global Prostate Cancer Treatment Drugs Revenue by Players (2016-2018)
  3.2.2 Global Prostate Cancer Treatment Drugs Revenue Market Share by Players (2016-2018)
3.3 Global Prostate Cancer Treatment Drugs Sale Price by Players
3.4 Global Prostate Cancer Treatment Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Prostate Cancer Treatment Drugs Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Prostate Cancer Treatment Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 PROSTATE CANCER TREATMENT DRUGS BY REGIONS

4.1 Prostate Cancer Treatment Drugs by Regions
  4.1.1 Global Prostate Cancer Treatment Drugs Consumption by Regions
  4.1.2 Global Prostate Cancer Treatment Drugs Value by Regions
4.2 Americas Prostate Cancer Treatment Drugs Consumption Growth
4.3 APAC Prostate Cancer Treatment Drugs Consumption Growth
4.4 Europe Prostate Cancer Treatment Drugs Consumption Growth
4.5 Middle East & Africa Prostate Cancer Treatment Drugs Consumption Growth

5 AMERICAS

5.1 Americas Prostate Cancer Treatment Drugs Consumption by Countries
  5.1.1 Americas Prostate Cancer Treatment Drugs Consumption by Countries (2013-2018)
  5.1.2 Americas Prostate Cancer Treatment Drugs Value by Countries (2013-2018)
5.2 Americas Prostate Cancer Treatment Drugs Consumption by Type
5.3 Americas Prostate Cancer Treatment Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Prostate Cancer Treatment Drugs Consumption by Countries
  6.1.1 APAC Prostate Cancer Treatment Drugs Consumption by Countries (2013-2018)
  6.1.2 APAC Prostate Cancer Treatment Drugs Value by Countries (2013-2018)
6.2 APAC Prostate Cancer Treatment Drugs Consumption by Type
6.3 APAC Prostate Cancer Treatment Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Prostate Cancer Treatment Drugs by Countries
  7.1.1 Europe Prostate Cancer Treatment Drugs Consumption by Countries (2013-2018)
  7.1.2 Europe Prostate Cancer Treatment Drugs Value by Countries (2013-2018)
7.2 Europe Prostate Cancer Treatment Drugs Consumption by Type
7.3 Europe Prostate Cancer Treatment Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Prostate Cancer Treatment Drugs by Countries
  8.1.1 Middle East & Africa Prostate Cancer Treatment Drugs Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Prostate Cancer Treatment Drugs Value by Countries (2013-2018)
8.2 Middle East & Africa Prostate Cancer Treatment Drugs Consumption by Type
8.3 Middle East & Africa Prostate Cancer Treatment Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Prostate Cancer Treatment Drugs Distributors
10.3 Prostate Cancer Treatment Drugs Customer

11 GLOBAL PROSTATE CANCER TREATMENT DRUGS MARKET FORECAST

11.1 Global Prostate Cancer Treatment Drugs Consumption Forecast (2018-2023)
11.2 Global Prostate Cancer Treatment Drugs Forecast by Regions
  11.2.1 Global Prostate Cancer Treatment Drugs Forecast by Regions (2018-2023)
  11.2.2 Global Prostate Cancer Treatment Drugs Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Prostate Cancer Treatment Drugs Forecast by Type
11.8 Global Prostate Cancer Treatment Drugs Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Tolmar
  12.1.1 Company Details
  12.1.2 Prostate Cancer Treatment Drugs Product Offered
  12.1.3 Tolmar Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Tolmar News
12.2 Astellas Pharma
  12.2.1 Company Details
  12.2.2 Prostate Cancer Treatment Drugs Product Offered
  12.2.3 Astellas Pharma Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Astellas Pharma News
12.3 AstraZeneca
  12.3.1 Company Details
  12.3.2 Prostate Cancer Treatment Drugs Product Offered
  12.3.3 AstraZeneca Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 AstraZeneca News
12.4 Ferring Pharmaceuticals
  12.4.1 Company Details
  12.4.2 Prostate Cancer Treatment Drugs Product Offered
  12.4.3 Ferring Pharmaceuticals Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Ferring Pharmaceuticals News
12.5 Johnson & Johnson
  12.5.1 Company Details
  12.5.2 Prostate Cancer Treatment Drugs Product Offered
  12.5.3 Johnson & Johnson Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Johnson & Johnson News
12.6 Abbott
  12.6.1 Company Details
  12.6.2 Prostate Cancer Treatment Drugs Product Offered
  12.6.3 Abbott Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Abbott News
12.7 Sanofi
  12.7.1 Company Details
  12.7.2 Prostate Cancer Treatment Drugs Product Offered
  12.7.3 Sanofi Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Sanofi News
12.8 Ipsen
  12.8.1 Company Details
  12.8.2 Prostate Cancer Treatment Drugs Product Offered
  12.8.3 Ipsen Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Ipsen News
12.9 Novartis
  12.9.1 Company Details
  12.9.2 Prostate Cancer Treatment Drugs Product Offered
  12.9.3 Novartis Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Novartis News
12.10 Bayer
  12.10.1 Company Details
  12.10.2 Prostate Cancer Treatment Drugs Product Offered
  12.10.3 Bayer Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Bayer News

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Prostate Cancer Treatment Drugs
Table Product Specifications of Prostate Cancer Treatment Drugs
Figure Prostate Cancer Treatment Drugs Report Years Considered
Figure Market Research Methodology
Figure Global Prostate Cancer Treatment Drugs Consumption Growth Rate 2013-2023 (MT)
Figure Global Prostate Cancer Treatment Drugs Value Growth Rate 2013-2023 ($ Millions)
Table Prostate Cancer Treatment Drugs Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Enzalutamid
Table Major Players of Enzalutamid
Figure Product Picture of Abiraterone
Table Major Players of Abiraterone
Figure Product Picture of Leuprolide
Table Major Players of Leuprolide
Figure Product Picture of Goserelin
Table Major Players of Goserelin
Figure Product Picture of Triptorelin
Table Major Players of Triptorelin
Figure Product Picture of Histrelin
Table Major Players of Histrelin
Figure Product Picture of Degarelix
Table Major Players of Degarelix
Figure Product Picture of Sipuleucel-T
Table Major Players of Sipuleucel-T
Figure Product Picture of Docetaxel
Table Major Players of Docetaxel
Figure Product Picture of Cabazitaxel
Table Major Players of Cabazitaxel
Table Global Consumption Sales by Type (2013-2018)
Table Global Prostate Cancer Treatment Drugs Consumption Market Share by Type (2013-2018)
Figure Global Prostate Cancer Treatment Drugs Consumption Market Share by Type (2013-2018)
Table Global Prostate Cancer Treatment Drugs Revenue by Type (2013-2018) ($ million)
Table Global Prostate Cancer Treatment Drugs Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Prostate Cancer Treatment Drugs Value Market Share by Type (2013-2018)
Table Global Prostate Cancer Treatment Drugs Sale Price by Type (2013-2018)
Figure Prostate Cancer Treatment Drugs Consumed in Hospital
Figure Global Prostate Cancer Treatment Drugs Market: Hospital (2013-2018) (MT)
Figure Global Prostate Cancer Treatment Drugs Market: Hospital (2013-2018) ($ Millions)
Figure Global Hospital YoY Growth ($ Millions)
Figure Prostate Cancer Treatment Drugs Consumed in Research Institution
Figure Global Prostate Cancer Treatment Drugs Market: Research Institution (2013-2018) (MT)
Figure Global Prostate Cancer Treatment Drugs Market: Research Institution (2013-2018) ($ Millions)
Figure Global Research Institution YoY Growth ($ Millions)
Figure Prostate Cancer Treatment Drugs Consumed in Clinic
Figure Global Prostate Cancer Treatment Drugs Market: Clinic (2013-2018) (MT)
Figure Global Prostate Cancer Treatment Drugs Market: Clinic (2013-2018) ($ Millions)
Figure Global Clinic YoY Growth ($ Millions)
Figure Prostate Cancer Treatment Drugs Consumed in Drugstore
Figure Global Prostate Cancer Treatment Drugs Market: Drugstore (2013-2018) (MT)
Figure Global Prostate Cancer Treatment Drugs Market: Drugstore (2013-2018) ($ Millions)
Figure Global Drugstore YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Prostate Cancer Treatment Drugs Consumption Market Share by Application (2013-2018)
Figure Global Prostate Cancer Treatment Drugs Consumption Market Share by Application (2013-2018)
Table Global Prostate Cancer Treatment Drugs Value by Application (2013-2018)
Table Global Prostate Cancer Treatment Drugs Value Market Share by Application (2013-2018)
Figure Global Prostate Cancer Treatment Drugs Value Market Share by Application (2013-2018)
Table Global Prostate Cancer Treatment Drugs Sale Price by Application (2013-2018)
Table Global Prostate Cancer Treatment Drugs Sales by Players (2016-2018) (MT)
Table Global Prostate Cancer Treatment Drugs Sales Market Share by Players (2016-2018)
Figure Global Prostate Cancer Treatment Drugs Sales Market Share by Players in 2016
Figure Global Prostate Cancer Treatment Drugs Sales Market Share by Players in 2017
Table Global Prostate Cancer Treatment Drugs Revenue by Players (2016-2018) ($ Millions)
Table Global Prostate Cancer Treatment Drugs Revenue Market Share by Players (2016-2018)
Figure Global Prostate Cancer Treatment Drugs Revenue Market Share by Players in 2016
Figure Global Prostate Cancer Treatment Drugs Revenue Market Share by Players in 2017
Table Global Prostate Cancer Treatment Drugs Sale Price by Players (2016-2018)
Figure Global Prostate Cancer Treatment Drugs Sale Price by Players in 2017
Table Global Prostate Cancer Treatment Drugs Manufacturing Base Distribution and Sales Area by Players
Table Players Prostate Cancer Treatment Drugs Products Offered
Table Prostate Cancer Treatment Drugs Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Prostate Cancer Treatment Drugs Consumption by Regions 2013-2018 (MT)
Table Global Prostate Cancer Treatment Drugs Consumption Market Share by Regions 2013-2018
Figure Global Prostate Cancer Treatment Drugs Consumption Market Share by Regions 2013-2018
Table Global Prostate Cancer Treatment Drugs Value by Regions 2013-2018 ($ Millions)
Table Global Prostate Cancer Treatment Drugs Value Market Share by Regions 2013-2018
Figure Global Prostate Cancer Treatment Drugs Value Market Share by Regions 2013-2018
Figure Americas Prostate Cancer Treatment Drugs Consumption 2013-2018 (MT)
Figure Americas Prostate Cancer Treatment Drugs Value 2013-2018 ($ Millions)
Figure APAC Prostate Cancer Treatment Drugs Consumption 2013-2018 (MT)
Figure APAC Prostate Cancer Treatment Drugs Value 2013-2018 ($ Millions)
Figure Europe Prostate Cancer Treatment Drugs Consumption 2013-2018 (MT)
Figure Europe Prostate Cancer Treatment Drugs Value 2013-2018 ($ Millions)
Figure Middle East & Africa Prostate Cancer Treatment Drugs Consumption 2013-2018 (MT)
Figure Middle East & Africa Prostate Cancer Treatment Drugs Value 2013-2018 ($ Millions)
Table Americas Prostate Cancer Treatment Drugs Consumption by Countries (2013-2018) (MT)
Table Americas Prostate Cancer Treatment Drugs Consumption Market Share by Countries (2013-2018)
Figure Americas Prostate Cancer Treatment Drugs Consumption Market Share by Countries in 2017
Table Americas Prostate Cancer Treatment Drugs Value by Countries (2013-2018) ($ Millions)
Table Americas Prostate Cancer Treatment Drugs Value Market Share by Countries (2013-2018)
Figure Americas Prostate Cancer Treatment Drugs Value Market Share by Countries in 2017
Table Americas Prostate Cancer Treatment Drugs Consumption by Type (2013-2018) (MT)
Table Americas Prostate Cancer Treatment Drugs Consumption Market Share by Type (2013-2018)
Figure Americas Prostate Cancer Treatment Drugs Consumption Market Share by Type in 2017
Table Americas Prostate Cancer Treatment Drugs Consumption by Application (2013-2018) (MT)
Table Americas Prostate Cancer Treatment Drugs Consumption Market Share by Application (2013-2018)
Figure Americas Prostate Cancer Treatment Drugs Consumption Market Share by Application in 2017
Figure United States Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure United States Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Figure Canada Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure Canada Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Figure Mexico Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure Mexico Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Table APAC Prostate Cancer Treatment Drugs Consumption by Countries (2013-2018) (MT)
Table APAC Prostate Cancer Treatment Drugs Consumption Market Share by Countries (2013-2018)
Figure APAC Prostate Cancer Treatment Drugs Consumption Market Share by Countries in 2017
Table APAC Prostate Cancer Treatment Drugs Value by Countries (2013-2018) ($ Millions)
Table APAC Prostate Cancer Treatment Drugs Value Market Share by Countries (2013-2018)
Figure APAC Prostate Cancer Treatment Drugs Value Market Share by Countries in 2017
Table APAC Prostate Cancer Treatment Drugs Consumption by Type (2013-2018) (MT)
Table APAC Prostate Cancer Treatment Drugs Consumption Market Share by Type (2013-2018)
Figure APAC Prostate Cancer Treatment Drugs Consumption Market Share by Type in 2017
Table APAC Prostate Cancer Treatment Drugs Consumption by Application (2013-2018) (MT)
Table APAC Prostate Cancer Treatment Drugs Consumption Market Share by Application (2013-2018)
Figure APAC Prostate Cancer Treatment Drugs Consumption Market Share by Application in 2017
Figure China Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure China Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Figure Japan Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure Japan Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Figure Korea Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure Korea Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure Southeast Asia Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Figure India Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure India Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Figure Australia Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure Australia Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Table Europe Prostate Cancer Treatment Drugs Consumption by Countries (2013-2018) (MT)
Table Europe Prostate Cancer Treatment Drugs Consumption Market Share by Countries (2013-2018)
Figure Europe Prostate Cancer Treatment Drugs Consumption Market Share by Countries in 2017
Table Europe Prostate Cancer Treatment Drugs Value by Countries (2013-2018) ($ Millions)
Table Europe Prostate Cancer Treatment Drugs Value Market Share by Countries (2013-2018)
Figure Europe Prostate Cancer Treatment Drugs Value Market Share by Countries in 2017
Table Europe Prostate Cancer Treatment Drugs Consumption by Type (2013-2018) (MT)
Table Europe Prostate Cancer Treatment Drugs Consumption Market Share by Type (2013-2018)
Figure Europe Prostate Cancer Treatment Drugs Consumption Market Share by Type in 2017
Table Europe Prostate Cancer Treatment Drugs Consumption by Application (2013-2018) (MT)
Table Europe Prostate Cancer Treatment Drugs Consumption Market Share by Application (2013-2018)
Figure Europe Prostate Cancer Treatment Drugs Consumption Market Share by Application in 2017
Figure Germany Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure Germany Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Figure France Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure France Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Figure UK Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure UK Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Figure Italy Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure Italy Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Figure Russia Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure Russia Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Figure Spain Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure Spain Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Prostate Cancer Treatment Drugs Consumption by Countries (2013-2018) (MT)
Table Middle East & Africa Prostate Cancer Treatment Drugs Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Prostate Cancer Treatment Drugs Consumption Market Share by Countries in 2017
Table Middle East & Africa Prostate Cancer Treatment Drugs Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Prostate Cancer Treatment Drugs Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Prostate Cancer Treatment Drugs Value Market Share by Countries in 2017
Table Middle East & Africa Prostate Cancer Treatment Drugs Consumption by Type (2013-2018) (MT)
Table Middle East & Africa Prostate Cancer Treatment Drugs Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Prostate Cancer Treatment Drugs Consumption Market Share by Type in 2017
Table Middle East & Africa Prostate Cancer Treatment Drugs Consumption by Application (2013-2018) (MT)
Table Middle East & Africa Prostate Cancer Treatment Drugs Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Prostate Cancer Treatment Drugs Consumption Market Share by Application in 2017
Figure Egypt Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure Egypt Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Figure South Africa Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure South Africa Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Figure Israel Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure Israel Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Figure Turkey Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure Turkey Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)
Figure GCC Countries Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)
Table Prostate Cancer Treatment Drugs Distributors List
Table Prostate Cancer Treatment Drugs Customer List
Figure Global Prostate Cancer Treatment Drugs Consumption Growth Rate Forecast (2018-2023) (MT)
Figure Global Prostate Cancer Treatment Drugs Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Prostate Cancer Treatment Drugs Consumption Forecast by Countries (2018-2023) (MT)
Table Global Prostate Cancer Treatment Drugs Consumption Market Forecast by Regions
Table Global Prostate Cancer Treatment Drugs Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Prostate Cancer Treatment Drugs Value Market Share Forecast by Regions
Figure Americas Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Americas Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure APAC Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure APAC Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure Europe Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Europe Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure Middle East & Africa Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Middle East & Africa Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure United States Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure United States Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure Canada Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Canada Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure Mexico Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Mexico Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure Brazil Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Brazil Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure China Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure China Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure Japan Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Japan Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure Korea Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Korea Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure Southeast Asia Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Southeast Asia Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure India Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure India Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure Australia Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Australia Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure Germany Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Germany Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure France Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure France Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure UK Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure UK Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure Italy Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Italy Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure Russia Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Russia Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure Spain Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Spain Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure Egypt Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Egypt Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure South Africa Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure South Africa Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure Israel Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Israel Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure Turkey Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure Turkey Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Figure GCC Countries Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)
Figure GCC Countries Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)
Table Global Prostate Cancer Treatment Drugs Consumption Forecast by Type (2018-2023) (MT)
Table Global Prostate Cancer Treatment Drugs Consumption Market Share Forecast by Type (2018-2023)
Table Global Prostate Cancer Treatment Drugs Value Forecast by Type (2018-2023) ($ Millions)
Table Global Prostate Cancer Treatment Drugs Value Market Share Forecast by Type (2018-2023)
Table Global Prostate Cancer Treatment Drugs Consumption Forecast by Application (2018-2023) (MT)
Table Global Prostate Cancer Treatment Drugs Consumption Market Share Forecast by Application (2018-2023)
Table Global Prostate Cancer Treatment Drugs Value Forecast by Application (2018-2023) ($ Millions)
Table Global Prostate Cancer Treatment Drugs Value Market Share Forecast by Application (2018-2023)
Table Tolmar Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Tolmar Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Tolmar Prostate Cancer Treatment Drugs Market Share (2016-2018)
Table Astellas Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astellas Pharma Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Astellas Pharma Prostate Cancer Treatment Drugs Market Share (2016-2018)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure AstraZeneca Prostate Cancer Treatment Drugs Market Share (2016-2018)
Table Ferring Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ferring Pharmaceuticals Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Ferring Pharmaceuticals Prostate Cancer Treatment Drugs Market Share (2016-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Johnson & Johnson Prostate Cancer Treatment Drugs Market Share (2016-2018)
Table Abbott Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Abbott Prostate Cancer Treatment Drugs Market Share (2016-2018)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sanofi Prostate Cancer Treatment Drugs Market Share (2016-2018)
Table Ipsen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ipsen Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Ipsen Prostate Cancer Treatment Drugs Market Share (2016-2018)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis Prostate Cancer Treatment Drugs Market Share (2016-2018)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Bayer Prostate Cancer Treatment Drugs Market Share (2016-2018)